Biogen Inc. (NASDAQ:BIIB):
On 14-05-2019 (Tuesday), Biogen Inc. (NASDAQ:BIIB)’s price settled at $229.18 with the percent change of 1.56%. The company has its outstanding shares of 195.81 Million. A total of 1891386 shares exchanged at hands and its Average Volume (3 months) is 2.49 Million. The company has a market cap of $44.19 Billion.
The highest price of BIIB touched in the last 12 month was $388.67 and the lowest price it hit in the same period was $216.12. Stock’s distance from 52 week High is -41.03% and the distance from 52 week Low is 6.04%.
Performance Overview of Biogen Inc. (NASDAQ:BIIB)
Biogen Inc. (NASDAQ:BIIB) currently shows its YTD (Year to Date) performance of -25.01 percent, whereas its Weekly performance stands at -4.41%. The Monthly and Yearly performances are -3.49 percent and -17.64 percent respectively.
Earnings and Revenue Snapshot of Biogen Inc. (NASDAQ:BIIB)
Biogen Inc. (NASDAQ:BIIB)’s Average Earnings Estimate for the Current Fiscal quarter is $7.47, according to consensus of 26 analysts. They are also projecting the Low EPS estimate of $6.26 and the High EPS estimate of $8.11.
The company’s Average Revenue Estimate for the current quarter is $3.47 Billion, while Low and High Revenue Estimates are $3.36 Billion and $3.62 Billion respectively. These Revenue projections are a consensus of 23 Analysts.
Price Insight of Biogen Inc. (NASDAQ:BIIB)
Price target given by certain analysts help investors in deciding about buying, selling or holding a stock. Analyst’s mean target price for the company is $261.62. The SMA20 for the stock is at -0.03 percent, SMA50 stands at -9.79 percent, while SMA200 is -26.15 Percent, according to Finviz reported data.
Return on Assets (ROA) value of the stock is 18.4 Percent. The Return on Equity (ROE) and Return on Investment (ROI) values are 35.3 percent and 23.6 percent respectively. Biogen Inc. (NASDAQ:BIIB) has an average true range (ATR) of 6.13
Profitability and Ratings Review of Biogen Inc. (NASDAQ:BIIB)
Biogen Inc. (NASDAQ:BIIB)’s profitability analysis greatly helps in making investment decision. Net profit margin of Biogen Inc. was recorded at 33.8 percent, operating profit margin was 42.4 percent, while gross profit margin stands at 85.7 percent. Beta factor was calculated at 0.97. Relative Strength Index (RSI) for BIIB is at 35.75.
Biogen Inc. (NASDAQ:BIIB) was covered by a number of analysts recently, 1 rated the stock as Buy, 4 rated Outperform, 24 rated Hold, 1 gave an Underperform and 0 rated sell.
OraSure Technologies, Inc. (NASDAQ:OSUR)
OraSure Technologies, Inc. (NASDAQ:OSUR) ended its previous trading session at $8.74 with the gain of 2.58% on 14-05-2019 (Tuesday). The market capitalization of the company is $518.27 Million. Overall, 679487 shares exchanged hands versus its average volume of $664.57 Million. OraSure Technologies, Inc. is -51.36% below its 1-Year High which is $17.97. OraSure Technologies, Inc. (NASDAQ:OSUR) has a difference of 5.68% from its 1 year low which stands at $8.27.
OraSure Technologies, Inc. (NASDAQ:OSUR) Analysts Coverage
Looking at Recommendation Trends of the stock polled by Reuters. For the Current month, 0 analysts have assigned this stock as Buy where 0 assigned Outperform, 4 analysts believe it’s a Hold, 0 said Underperform and only 0 assigned Sell rating.
Revenue and Earnings Outlook of OraSure Technologies, Inc. (NASDAQ:OSUR)
According to 4 analysts, the Average Revenue Estimate is $41.15 Million for the current Fiscal quarter. The Low Revenue estimate is $40.18 Million, while High Revenue estimate is $42.04 Million.
For the current Fiscal Quarter, 4 analysts on average are expecting earnings of $0.02 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $0.02 whereas, High Estimate is $0.03
OraSure Technologies, Inc. (NASDAQ:OSUR) Performance and Ratio Review
OraSure Technologies, Inc. (NASDAQ:OSUR) performance during the last one year degraded -47.63 percent, while its year to date (YTD) performance showed a negative trend of -27.05 percent. The stock pessimistic -16.8 percent over the past 1 month. Its weekly performance showed downward trend of -14.8 percent.
The Price to Sales (P/S) of OraSure Technologies, Inc. (NASDAQ:OSUR) is 2.85, while P/B (Price to Book) stands at 1.84. The company P/E (price to earnings) ratio is 13.99 and Forward P/E ratio is 26.38, while its P/C (price to Cash) ratio stands at 3.31.
Technical Indicators of OraSure Technologies, Inc. (NASDAQ:OSUR)
OraSure Technologies, Inc.’s RSI (Relative strength index) is at 33.07, its ATR (Average True Range) value is 0.46, while its Beta factor was calculated at 1.19. OSUR has been given an analysts’ mean target of 11.33.